Our Technology



Bio-MM Microsphere Extended-Release "Depot" Injectable DDS Technology

For an extended 1-week, 1-month or 3-month treatment of cancers, the Bio-MM DDS is applied to incorporate the drug into microsphere delivery systems via intra-muscular or subcutaneous depot delivery over a period of prolonged delivery time.

Extended-Release Microsphere Injection

  • Prolonged Action for 1 week, 1 month, 2 months or 3 months
  • Precision and Much Narrower Particle Size Distribution
  • Significantly Reduced Initial Drug Release Surge
  • Significantly Shortened Onset Time
  • Improved In-vivo Stability
  • Reduced Toxicity

Bio-MM Microsphere Injection 

  • Prolonged Circulating Half-life
  • Improved Solubility
  • Reduced Proteolytic Degradation
  • Improved In-vivo Stability
  • Less Frequent Administration: Improved Patient Compliance